Ralph Lippe, PhD

AbbVie
Libertyville, IL, United States

Scientific Director, Global Medical Affairs

Presentation(s):

• 2245: Drug Survival of Risankizumab vs Other Biologics After 13 Months of Treatment Among Patients with PsA in the Multicountry Postmarketing Observational VALUE Study

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.